Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:378-380
doi: 10.1161/01.CIR.0000046342.46135.CB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hasenfuss, G.
Right arrow Articles by Seidler, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasenfuss, G.
Right arrow Articles by Seidler, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Contractile function
Right arrow Congestive
Right arrow Animal models of human disease
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Cell signalling/signal transduction
Right arrow Heart failure - basic studies
Right arrow Ion channels/membrane transport
Right arrowRelated Article

(Circulation. 2003;107:378.)
© 2003 American Heart Association, Inc.


Editorial

Treatment of Heart Failure Through Stabilization of the Cardiac Ryanodine Receptor

Gerd Hasenfuss, MD; Tim Seidler, MD

From the Department of Cardiology and Pneumology, University of Göttingen, Göttingen, Germany.

Correspondence to Gerd Hasenfuss, MD, University of Göttingen, Cardiology and Pneumology, Robert-Koch-Straße 40, 37075 Göttingen, Germany. E-mail hasenfus@med.uni-goettingen.de


Key Words: Editorials • heart failure • calcium • sarcoplasmic reticulum


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The key event in cardiac excitation-contraction coupling is calcium-induced calcium release from the sarcoplasmic reticulum (SR) after activation of cardiac ryanodine receptors (RyRs).1 Two distinct genes encode the cardiac (RyR2) and skeletal muscle (RyR1) specific receptors.2,3 A third type of ryanodine receptor (RyR3) exhibits functional properties distinct from those of RyR1 and RyR2.4 The RyR channels form a tetrameric structure composed of 4 monomeric subunits, each of about 565 000 Daltons. These channels are about 10 times larger than the voltage-gated Ca2+ and Na+ channels.5 RyR2 opening increases cytosolic Ca2+ from approximately 100 nmol/L to 1 µmol/L with consecutive activation of contractile proteins. The RyR was recently shown to be a macromolecular complex including protein kinase A (PKA) and its anchoring protein (mAKAP), the protein phosphatases PP1 and PP2A, sorcin, calmodulin, FK506 binding protein (FKBP), and other proteins.5 FKBP12.0 and its isoform FKBP12.6 seem to play an important role for the regulation of the RyR. The immunophilin FKBP12 was originally identified as the cytosolic receptor for the immunosuppressant FK506 in T-cells. FKBP12 is a cis/trans peptidyl-prolyl isomerase. However, it is unlikely that this enzymatic activity is directly involved in RyR regulation. FKBP12 has been postulated to bind to the RyR with a stoichiometry of 4 or less FKBP12 molecules per single functional channel.6 FKBP12.0 is tightly bound to and regulates the function of the skeletal RyR1, whereas RyR2 has been found to co-purify selectively with FKBP12.6 despite a higher expression level of FKBP12.0 in cardiac myocytes.7 However, considerable species differences . . . [Full Text of this Article]


Related Article:

FKBP12.6-Mediated Stabilization of Calcium-Release Channel (Ryanodine Receptor) as a Novel Therapeutic Strategy Against Heart Failure
Masafumi Yano, Shigeki Kobayashi, Masateru Kohno, Masahiro Doi, Takahiro Tokuhisa, Shinichi Okuda, Masae Suetsugu, Takayuki Hisaoka, Masakazu Obayashi, Tomoko Ohkusa, Michihiro Kohno, and Masunori Matsuzaki
Circulation 2003 107: 477-484. [Abstract] [Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. P. Katra, T. Oya, G. S. Hoeker, and K. R. Laurita
Ryanodine receptor dysfunction and triggered activity in the heart
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2144 - H2151.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Feelisch
Nitroxyl gets to the heart of the matter
PNAS, April 29, 2003; 100(9): 4978 - 4980.
[Full Text] [PDF]